Holen Sie sich die Stockscreener-App
3.315
1.34%
-0.045
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Anavex Life Sciences Corp Aktie (AVXL) Neueste Nachrichten
Anavex appoints interim CEO following leadership change By Investing.com - Investing.com Canada
CEO ousted as Anavex (NASDAQ: AVXL) board installs interim chief and eyes 10-Q delay - Stock Titan
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating - Investing.com
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating By Investing.com - Investing.com Canada
MSN Money - MSN
Director Axel Paeger files initial Form 3 for Anavex (AVXL) - Stock Titan
AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
AVXL stock soars after Anavex’s new data suggests its Alzheimer’s drug may slow brain shrinkage - MSN
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's - MSN
Anavex stock slides after hours on EMA panel’s negative Alzheimer’s drug opinion — retail traders talk buyout potential - MSN
What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks - Yahoo Finance
Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN
Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Anavex (AVXL) Stock: Buy or Sell? (+7.06%) 2026-04-18High Interest Stocks - Xã Vĩnh Công
AVXL | Anavex Life Sciences Insider Trading - Quiver Quantitative
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology between Autism and Alzheimer's disease - marketscreener.com
Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference - MarketBeat
Anavex Life Sciences Advances Blarcamesine Research, Highlighting Shared Autophagy Mechanisms in Autism and Alzheimer’s Disease - Quiver Quantitative
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease - marketscreener.com
Autistic adults had up to 8x dementia rates in research Anavex cites - Stock Titan
Anavex links autism and Alzheimer’s via autophagy dysfunction - Investing.com
Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Aug Rallies: Does Anavex Life Sciences Corp have strong fundamentalsMarket Activity Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Shareholders to Connect - ACCESS Newswire
AVXL Technical Analysis | Trend, Signals & Chart Patterns | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AVXL Q1 2026 Earnings: Anavex Life Sciences beats EPS ests, no revenueConsensus Forecast - UBND thành phố Hải Phòng
Aug Retail: Is Anavex Life Sciences Corp stock trending bullish2026 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Anavex Life Sciences Corp. to Present at 25th Annual Needham Virtual Healthcare Conference - Quiver Quantitative
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:AVXL | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Investors to Connect - ACCESS Newswire
Anavex Life Sciences Corp. (AVXL) stock price, news, quote and history - Yahoo Finance UK
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Investors to Connect | NDAQ:AVXL | Press Release - stockhouse.com
3 Promising Penny Stocks With At Least $200M Market Cap - Sahm
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 635% Upside in Biotechnology - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Anavex Life Sciences Corp (12X1.HM) Recent Insider Transactions - Yahoo! Finance Canada
AVXL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Anavex Life Sciences' (AVXL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
Anavex Life Sciences Provides Comprehensive Regulatory Update - The Manila Times
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):